have confirmed the negative correlations of HOXA9 and IDD, in which HOXA9 played pivotal roles in FAS-mediated apoptosis of NP cells and HOXA9 could serve as potential therapeutic target in the treatment of IDD (82). This evidence concerns the gene FAS and intervertebral disk degenerative disorder.